Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William A Murphy

Showing results (21-30 of 58) with videos related to

Pageof 6
Sort By:
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|January 17, 2003
Responses to human CGRP, ADM, and PAMP in human thymic arteriesHunter C Champion, Trinity J Bivalacqua, Robert L Pierce, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|January 23, 2009
Expression analysis of fibroblast growth factor-23, matrix extracellular phosphoglycoprotein, secreted frizzled-related protein-4, and fibroblast growth factor-7: identification of fibroblast growth factor-23 and matrix extracellular phosphoglycoprotein as major factors involved in tumor-induced osteomalaciaMouhammed Amir Habra, Camilo Jimenez, Su-Chen Eileen Huang, et al.
JCO Clinical Cancer Informatics|January 5, 2024
Cancer Radiomic and Perfusion Imaging Automated Framework: Validation on Musculoskeletal TumorsElvis Duran Sierra, Raul Valenzuela, Mathew A Canjirathinkal, et al.
Bonekey Reports|December 27, 2016
Ibandronate for the prevention of bone loss after allogeneic stem cell transplantation for hematologic malignancies: a randomized-controlled trialHuifang Lu, Richard E Champlin, Uday Popat, et al.
Frontiers in Pharmacology|January 28, 2026
Development of an <i>in vitro</i> metabolic dysfunction-associated steatohepatitis model to investigate altered drug metabolizing enzymes, transport proteins, and hepatobiliary dispositionWilliam A Murphy, Sarina Kyburz, Henry Ho, et al.
Immunotherapy|September 9, 2020
Osteonecrosis of the jaw induced by treatment with anti-PD-1 immunotherapy: a case reportXerxes Pundole, Amy Little Jones, Michael T Tetzlaff, et al.
Cellular and Molecular Life Sciences : CMLS|December 30, 2025
Evaluation of a human 3D multicellular hepatic spheroid model as a platform for studying hepatic transportersMattie Hartauer, Henry Ho, Meimei Wan, et al.
AJR. American Journal of Roentgenology|February 22, 2007
Imaging characteristics of locally recurrent tumors of boneColleen M Costelloe, Rajendra Kumar, Alan W Yasko, et al.
Clinical Pharmacology and Therapeutics|April 16, 2022
Considerations for Physiologically Based Modeling in Liver Disease: From Nonalcoholic Fatty Liver (NAFL) to Nonalcoholic Steatohepatitis (NASH)William A Murphy, Jeffry Adiwidjaja, Noora Sjöstedt, et al.
Bioorganic & Medicinal Chemistry Letters|May 5, 2021
Design and evaluation of 1,2,3-dithiazoles and fused 1,2,4-dithiazines as anti-cancer agentsKaitlyn A Maffuid, Maria Koyioni, Chad D Torrice, et al.
Pageof 6

Showing results (21-30 of 58) with videos related to

Sort By:
Pageof 6
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|January 17, 2003
Responses to human CGRP, ADM, and PAMP in human thymic arteriesHunter C Champion, Trinity J Bivalacqua, Robert L Pierce, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|January 23, 2009
Expression analysis of fibroblast growth factor-23, matrix extracellular phosphoglycoprotein, secreted frizzled-related protein-4, and fibroblast growth factor-7: identification of fibroblast growth factor-23 and matrix extracellular phosphoglycoprotein as major factors involved in tumor-induced osteomalaciaMouhammed Amir Habra, Camilo Jimenez, Su-Chen Eileen Huang, et al.
JCO Clinical Cancer Informatics|January 5, 2024
Cancer Radiomic and Perfusion Imaging Automated Framework: Validation on Musculoskeletal TumorsElvis Duran Sierra, Raul Valenzuela, Mathew A Canjirathinkal, et al.
Bonekey Reports|December 27, 2016
Ibandronate for the prevention of bone loss after allogeneic stem cell transplantation for hematologic malignancies: a randomized-controlled trialHuifang Lu, Richard E Champlin, Uday Popat, et al.
Frontiers in Pharmacology|January 28, 2026
Development of an <i>in vitro</i> metabolic dysfunction-associated steatohepatitis model to investigate altered drug metabolizing enzymes, transport proteins, and hepatobiliary dispositionWilliam A Murphy, Sarina Kyburz, Henry Ho, et al.
Immunotherapy|September 9, 2020
Osteonecrosis of the jaw induced by treatment with anti-PD-1 immunotherapy: a case reportXerxes Pundole, Amy Little Jones, Michael T Tetzlaff, et al.
Cellular and Molecular Life Sciences : CMLS|December 30, 2025
Evaluation of a human 3D multicellular hepatic spheroid model as a platform for studying hepatic transportersMattie Hartauer, Henry Ho, Meimei Wan, et al.
AJR. American Journal of Roentgenology|February 22, 2007
Imaging characteristics of locally recurrent tumors of boneColleen M Costelloe, Rajendra Kumar, Alan W Yasko, et al.
Clinical Pharmacology and Therapeutics|April 16, 2022
Considerations for Physiologically Based Modeling in Liver Disease: From Nonalcoholic Fatty Liver (NAFL) to Nonalcoholic Steatohepatitis (NASH)William A Murphy, Jeffry Adiwidjaja, Noora Sjöstedt, et al.
Bioorganic & Medicinal Chemistry Letters|May 5, 2021
Design and evaluation of 1,2,3-dithiazoles and fused 1,2,4-dithiazines as anti-cancer agentsKaitlyn A Maffuid, Maria Koyioni, Chad D Torrice, et al.
Pageof 6